Tofacitinib-Associated Cerebral Venous Sinus Thrombosis

Tofacitinib is a Janus kinase inhibitor indicated to treat adult patients with moderately to severely active ulcerative colitis (UC). Although thrombosis is a known adverse event of tofacitinib, there are no reports specific to cerebral venous sinus thrombosis (CVST). We present a report of a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakma, Zakaria, Gofman, Natalie, Brown, Danielle, Fitzgerald, Ethan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294923/
https://www.ncbi.nlm.nih.gov/pubmed/34307712
http://dx.doi.org/10.14309/crj.0000000000000632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294923/
https://www.ncbi.nlm.nih.gov/pubmed/34307712
http://dx.doi.org/10.14309/crj.0000000000000632

Ejemplares similares